Navigation Links
Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
Date:10/21/2010

velops novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical needs. Intercell's vaccine to prevent Japanese Encephalitis is the Company's first product on the market.

The Company's technology platform includes an antigen-discovery system and human anti-infective monoclonal antibody discovery system, adjuvants and a novel patch-based delivery system (Vaccine Patch, Vaccine Enhancement Patch). Based on these technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including GSK, Novartis, Merck & Co., Inc., Sanofi-Aventis, and Pfizer (formerly Wyeth).

The Company's pipeline of investigational products includes a Travelers' Diarrhea Vaccine Patch (Phase III), a Pseudomonas vaccine candidate (Phase II), a vaccine to prevent Pandemic Influenza combining our Vaccine Enhancement Patch with an injected vaccine (Phase II), a vaccine program for S. aureus, which is being developed with Merck & Co., Inc. (Phase II/III), as well as a vaccine candidate for Pneumococcus (Phase I). In addition, further products focused on infectious diseases are in pre-clinical development.

Intercell is listed on the Vienna stock exchange under the symbol "ICLL" (U.S. level one ADR symbol "INRLY").

(1) Rossignol JF. Thiazolides: a new class of antiviral drugs. Expert Opin Drug Metab Toxicol. 2009;5:667-674.

(2) Korba BE, Montero AB, Farrar K, et al. Nitazoxanide, tizoxanide, and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antivir Res. 2008;77:56-63.

(3) Korba BE, Elazar M, Lui P, et al. Studies of the potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob Agents Chemother. 2008;52:4069-4071.

(4) Yon C, Viswanathan P, Rossignol JF, Korba BE. Resistance to nitazoxanide is associated with alterations in the host and not the virus in HCV replicon
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
2. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
3. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
4. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
5. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
6. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
7. Romark Laboratories Raises $18 Million in Institutional Financing
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
10. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 About 8 million Americans have peripheral ... of fatty plaque in the arteries, according to recent ... and in incidences of diabetes and obesity, the ... Extremity Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... interested residents and fellows will be able to gain ...
(Date:8/27/2014)... LAKE CITY , Aug. 27, 2014 Varian ... will expand its current Salt Lake City ... currently underway outside of Utah to ... over the next 20 years. " ... engineering and technical talent, many of whom can be credited ...
(Date:8/27/2014)... 2014 Decision Resources Group finds that the ... Memphis health system and hospital sector in ... rivals Methodist Le Bonheur Healthcare and Baptist Memorial Health ... patient care. In addition, a national contract recently signed ... plan enrollment in the Memphis ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Memphis-area Health Systems Turn Attention to Clinical Integration 2
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203105/The-Outlook-for-Pharmaceuticals-in-Northern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory The Northern European ... pharmaceutical market value of over US$26 billion ...
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that it is scheduled to speak at the Lazard ... City.  The presentation is scheduled for Tuesday, November 15, ... the conference, the company will reaffirm its 2011 outlook ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Northern Europe 2The Outlook for Pharmaceuticals in Northern Europe 3The Outlook for Pharmaceuticals in Northern Europe 4Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 2Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 3Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 4
(Date:8/27/2014)... (PRWEB) August 27, 2014 The newest ... PA on Monday, September 8, 2014. This new 15,000 ... that features three primary care practices and walk-in laboratory ... is a very exciting endeavor for Abington Health as ... and CEO, Abington Health. “Establishing a location in Lower ...
(Date:8/27/2014)... 2014 (HealthDay News) -- Overconfident people are better at ... are, and therefore are more likely to get promotions ... The researchers added that these "self-deceived" people are also ... take greater risks. And finally, people who underestimate ... according to the British researchers. Their findings were published ...
(Date:8/27/2014)... Recent growth in health care spending for commercially insured ... medical services, rather than increased use, according to a ... for Health Policy & Clinical Practice, published in the ... Care . , There is increasing concern that consolidation ... prices faced by payers and, ultimately, consumers," said Carrie ...
(Date:8/27/2014)... August 27, 2014 Driven by the ... is expected to grow steadily during the next few ... reach 1.381 billion meters by end-2017. Tightness is an ... are one of the most-used parts in an automobile. ... stood at 995 million meters, up just under 15% ...
(Date:8/27/2014)... and Denver (PRWEB) August 27, 2014 ... , has broken ground on a 79,491 square foot ... Health hospital campus in Germantown, an unincorporated municipality located ... the third most populous place in Maryland, after Baltimore ... Holy Cross Germantown Hospital campus is one of three ...
Breaking Medicine News(10 mins):Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4
... With the cost of,medical care skyrocketing, a ... Health,Solutions finds that better coordination of in-home ... care and drastically reduce,cost., The Deloitte ... Home,",( http://www.deloitte.com/us/connectedcareathome ) promotes self-care and an,electronically ...
... March 8, 2008 Do you remember the seventh song ... yesterday? Most of us dont, thanks to a normal forgetting ... from our brains. Researchers at the Buck Institute now believe ... (AD) and that this effect is key to the profound ...
... Health and Financial ... Pharmaceutical Companies, NEW YORK and LONDON, March 12 ... and causing an,estimated 125,000 deaths per year in the United ... Eularis has,responded to this problem with a new report, available ...
... with dangerous germ, , , WEDNESDAY, March 12 (HealthDay News) -- ... their pets, but one thing you probably never thought you ... , However, according to a letter in the March 13 ... a German family appears to have done just that. Doctors ...
... Protein Corporation,(NYSE: OME ), the nation,s leading producer ... reported net income of $12.1 million,($0.72 a share) for ... income of $4.6 million ($0.19 a share) for the ... For the year ended December 31, 2007, the ...
... and SEATTLE, March 12 DocuSys, Inc., ... medication,management system provider, today announced that Harborview ... I adult and pediatric trauma center,serving a ... anesthesia,solutions, which will automate the documentation of ...
Cached Medicine News:Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 2Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 3Health News:Paradoxical Alzheimer's finding may shed new light on memory loss 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Woman and Cat Shared 'Super Bug' 2Health News:Woman and Cat Shared 'Super Bug' 3Health News:Omega Protein Reports 2007 Results 2Health News:Omega Protein Reports 2007 Results 3Health News:Omega Protein Reports 2007 Results 4Health News:Omega Protein Reports 2007 Results 5Health News:Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 2Health News:Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 3
The TS100-F trinocular model comes with a photo port that accepts Nikon's FX-III series photomicrographic systems, CCTV camera, or digital camera....
... TS100 is an innovative and ... high quality tool complements any ... increased stability - Nikon has ... resistant design that greatly reduces ...
Surgical drill bits, twist drills, HSS. Available in various sizes....
... These revised charts incorporate the slight change ... the 10 Sloan letters derived from the ... eyes during the ETDRS study. The original ... examination of 234 eyes. In addition to ...
Medicine Products: